P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study. (April 2023)

Record Type:
Journal Article
Title:
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study. (April 2023)
Main Title:
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
Authors:
Kümmel, S.
Schmid, P.
Harbeck, N.
Takahashi, M.
Untch, M.
Boileau, J.-F.
Cortes, J.
McArthur, H.
Dent, R.
O'Shaughnessy, J.
Pusztai, L.
Foukakis, T.
Park, Y.H.
Hui, R.
Cardoso, F.
Denkert, C.
Zhu, Y.
Pan, W.
Karantza, V.
Fasching, P.
Abstract:
Is Part Of:
Breast. Volume 68(2023)Supplement
Journal:
Breast
Issue:
Volume 68(2023)Supplement
Issue Display:
Volume 68, Issue 2023 (2023)
Year:
2023
Volume:
68
Issue:
2023
Issue Sort Value:
2023-0068-2023-0000
Page Start:
S63
Page End:
S64
Publication Date:
2023-04
Subjects:
Breast -- Diseases -- Periodicals
Breast -- Tumors -- Periodicals
Breast -- Periodicals
Electronic journals
Periodicals
616
Journal URLs:
http://www.sciencedirect.com/science/journal/09609776 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0960-9776;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/brst/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09609776 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09609776 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0960-9776(23)00242-4 ↗
Languages:
English
ISSNs:
0960-9776
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 2277.492700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
26156.xml